696
Participants
Start Date
September 30, 2010
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
TC-5214
Twice daily for 8 weeks.
Placebo
Twice daily for 8 weeks.
Research Site, Buenos Aires
Research Site, Mendoza
Research Site, Ciudad Autonoma Bs As, Cba
Research Site, Dublin
Research Site, Rio de Janeiro
Research Site, Novi Iskar
Research Site, Rousse
Research Site, Santiago
Research Site, Antofagasta
Research Site, Providencia Santiago
Research Site, Bello
Research Site, Bogota
Research Site, Pereira
Research Site, Santiago de Cali
Research Site, Rijeka
Research Site, Bully-les-Mines
Research Site, Caen
Research Site, Cherbourg
Research Site, Colmar
Research Site, Dole
Research Site, Douai
Research Site, Élancourt
Research Site, Montpellier
Research Site, Sartrouville
Research Site, Strasbourg
Research Site, Toulon
Research Site, Toulouse
Research Site, Tours
Research Site, Hüttenberg
Research Site, Bad Homburg
Research Site, Bielefeld
Research Site, Gelsenkirchen
Research Site, Schwerin
Research Site, Siegen
Research Site, Balassagyarmat
Research Site, Budapest
Research Site, Győr
Research Site, Bydgoszcz
Research Site, Bialystok
Research Site, Leszno
Research Site, Lublin
Research Site, Torun
Research Site, Arad
Research Site, Brasov
Research Site, Bucharest
Research Site, Cluj-Napoca
Research Site, Focşani
Research Site, Oradea
Research Site, Timișoara
Research Site, Arkhangelsk
Research Site, Chita
Research Site, Novosibirsk
Research Site, Petrozavodsk
Research Site, Saint Petersburg
Research Site, Tomsk
Research Site, Voronezh
Research Site, Yekaterinburg
Research Site, Kragujevac
Research Site, Niš
Research Site, Banská Štiavnica
Research Site, Bratislava
Research Site, Levice
Research Site, Prešov
Research Site, Rimavská Sobota
Research Site, Svidník
Research Site, Trenčín
Research Site, Bloemfontein
Research Site, Vereeniging
Research Site, Cape Town
Research Site, Centurion
Research Site, Durban
Research Site, George
Research Site, Paarl
Research Site, Port Elizabeth
Research Site, Alcalá de Henares
Research Site, Coslada
Research Site, Langreo
Research Site, Kharkiv
Research Site, Simferpool
Research Site, Vinnytsia
Research Site, Dnipropetrovsk
Research Site, Donetsk
Research Site, Kherson
Research Site, Kiev
Research Site, Lviv
Research Site, Poltava
Research Site, Ternopil
Lead Sponsor
Targacept Inc.
INDUSTRY
AstraZeneca
INDUSTRY